Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: MicroRNAs (miRNAs) regulate target genes at the post-transcriptional level and play important roles in cancer pathogenesis and development. Variation amongst individuals is a significant confounding factor in miRNA (or other) expression studies. The true character of biologically or clinically meaningful differential expression can be obscured by inter-patient variation. In this study we aim to identify miRNAs with consistent differential expression in multiple tumor types using a novel data analysis approach. METHODS: Using microarrays we profiled the expression of more than 700 miRNAs in 28 matched tumor/normal samples from 8 different tumor types (breast, colon, liver, lung, lymphoma, ovary, prostate and testis). This set is unique in putting emphasis on minimizing tissue type and patient related variability using normal and tumor samples from the same patient. We develop scores for comparing miRNA expression in the above matched sample data based on a rigorous characterization of the distribution of order statistics over a discrete state set, including exact p-values. Specifically, we compute a Rank Consistency Score (RCoS) for every miRNA measured in our data. Our methods are also applicable in various other contexts. We compare our methods, as applied to matched samples, to paired t-test and to the Wilcoxon Signed Rank test. RESULTS: We identify consistent (across the cancer types measured) differentially expressed miRNAs. 41 miRNAs are under-expressed in cancer compared to normal, at FDR (False Discovery Rate) of 0.05 and 17 are over-expressed at the same FDR level. Differentially expressed miRNAs include known oncomiRs (e.g miR-96) as well as miRNAs that were not previously universally associated with cancer. Specific examples include miR-133b and miR-486-5p, which are consistently down regulated and mir-629* which is consistently up regulated in cancer, in the context of our cohort. Data is available in GEO. Software is available at: http://bioinfo.cs.technion.ac.il/people/zohar/RCoS/
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 2×
“The raw and normalized data have been deposited in NCBI’s Gene Expression Omnibus [38] and are accessible through GEO Series accession number GSE14985 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE14985).”
MethodGolub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018 · cited 1×
“The importance of regulated activity of intact p53 in preventing tumor formation is indicated by the presence of mutations in the p53 pathway in nearly all cancers [17,18].”
BackgroundCirculating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111 · cited 1×
“For example, mir-15 and mir16 are frequently deleted and/or downregulated in B-cell chronic lymphocytic leukemia [23], miR-143 and miR-145 show decreased expression in colorectal neoplasia [24], and miR-155 is up-regulated in human B cell lymphomas [25].”
MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000610 · Cited by 754 · cited 1×
“miRNAs regulate target genes at the post-transcriptional level and play important roles in development as well as in cancer [9–11] and in other human diseases, including heart disease [12–14], schizophrenia [15] and psoriasis [16].”
BackgroundPerkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574 · cited 1×
“miRNAs regulate target genes at the post-transcriptional level and play important roles in development as well as in cancer [9–11] and in other human diseases, including heart disease [12–14], schizophrenia [15] and psoriasis [16].”
Background
Cited by
Cazzoli, R., Buttitta, F., Di Nicola, M., Malatesta, S., Marchetti, A., Rom, W. N., & Pass, H. I. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318299ac32 · Cited by 452
Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
Shen, J., Todd, N. W., Zhang, H., Yu, L., Lingxiao, X., Mei, Y., Guarnera, M., Liao, J., Chou, A., Lu, C. L., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.194 · Cited by 383
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
Yu, L., Todd, N. W., Xing, L., Xie, Y., Zhang, H., Liu, Z., Fang, H., Zhang, J., Katz, R. L., & Jiang, F. (2010) · International Journal of Cancer · doi:10.1002/ijc.25289 · Cited by 353
miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
Enerly, E., Steinfeld, I., Kleivi, K., Leivonen, S.-K., Aure, M. R., Russnes, H. G., Rønneberg, J. A., Johnsen, H., Navon, R., Rødland, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016915 · Cited by 310
Self-citationDong, P., Karaayvaz, M., Jia, N., Kaneuchi, M., Hamada, J., Watari, H., Sudo, S., Ju, J., & Sakuragi, N. (2013) · Oncogene · doi:10.1038/onc.2012.334 · Cited by 307
Hwang, J.-H., Voortman, J., Giovannetti, E., Steinberg, S. M., Leon, L. G., Kim, Y.-T., Funel, N., Park, J. K., Kim, M. A., Kang, G. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010630 · Cited by 290
Identification of Circulating MicroRNA Signatures for Breast Cancer Detection
Chan, M., Liaw, C. S., Ji, S. M., Tan, H. H., Wong, C. Y., Thike, A. A., Tan, P. H., Ho, G. H., & Lee, A. S.-G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3401 · Cited by 274
The prognostic and functional role of microRNAs in acute myeloid leukemia
Marcucci, G., Mrózek, K., Radmacher, M. D., Garzon, R., & Bloomfield, C. D. (2011) · Blood · doi:10.1182/blood-2010-09-191312 · Cited by 270
Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
Namløs, H. M., Meza-Zepeda, L. A., Barøy, T., Østensen, I. H. G., Kresse, S. H., Kuijjer, M. L., Serra, M., Bürger, H., Cleton-Jansen, A.-M., & Myklebost, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048086 · Cited by 264
Parikh, A., Lee, C., Joseph, P., Marchini, S., Baccarini, A., Kolev, V., Romualdi, C., Fruscio, R., Shah, H., Wang, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms3977 · Cited by 258
Oh, H.-K., Tan, A. L.-K., Das, K., Ooi, C.-H., Deng, N.-T., Tan, I. B., Beillard, E., Lee, J., Ramnarayanan, K., Rha, S.-Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3152 · Cited by 199
Levy-Jurgenson, A., Tekpli, X., Kristensen, V. N., & Yakhini, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-75708-z · Cited by 155
Self-citationWang, T.-H., Yeh, C.-T., Ho, J.-Y., Ng, K.-F., & Chen, T.-C. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22286 · Cited by 58
Metadata
- Authors
- Navon, R., Wang, H., Steinfeld, I., Tsalenko, A., Ben-Dor, A., & Yakhini, Z.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-11-25
- Volume
- 4
- Issue
- 11
- Pages
- e8003
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1968968087
- Cited by
- 165
- References
- 11
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.